FDA Announces Meeting of Clinical Hold Review Committee for Review of Investigational New Biological Products Trials

Summary

The FDA is hosting a meeting of the clinical hold review committee to review clinical holds on investigational new biological product trials, and is inviting biological companies to submit trials for review.